Skip to main content
FunPep Company Limited logo

FunPep Company Limited — Investor Relations & Filings

Ticker · 4881 ISIN · JP3802640007 T Manufacturing
Filings indexed 51 across all filing types
Latest filing 2026-03-24 Regulatory Filings
Country JP Japan
Listing T 4881

About FunPep Company Limited

https://www.funpep.co.jp/en/

FunPep Company Limited is a research and development firm specializing in therapeutic solutions derived from functional peptides. The company leverages the biological properties of peptides—short chains of amino acids—to develop a portfolio of products including pharmaceuticals, medical devices, and functional cosmetics. Its primary focus is on creating peptide-based medicines through two main platforms: functional peptides and antibody-inducing peptides. A key candidate from its functional peptide platform, SR-0379, is in late-stage clinical trials. The company is also advancing an allergy vaccine and developing next-generation formulation technologies for its antibody-inducing peptide platform.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act to confirm the accuracy of the contents of the Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS). The document does not contain the actual financial statements or substantive financial data of the report it references. FY 2025
2026-03-24 Japanese
有価証券報告書-第13期(2025/01/01-2025/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which translates to 'Annual Securities Report'. This is the standard, comprehensive annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2025. As it is the primary annual report for a Japanese company, it corresponds to the 10-K category in the provided schema. FY 2025
2026-03-24 Japanese
有価証券届出書(組込方式)
Regulatory Filings Classification · 100% confidence The document is a '有価証券届出書' (Securities Registration Statement) filed with the Kinki Finance Bureau. This is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan for the issuance of new shares and stock acquisition rights (warrants). It details the terms of the offering, the purpose of the capital raise, and the company's business operations. This falls under the category of Regulatory Filings (RNS) as it is a formal legal disclosure document.
2026-02-20 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2 of the Financial Instruments and Exchange Act of Japan. It accompanies the Second Quarter Report (第2四半期報告書) to confirm the accuracy of the financial statements. Since it is a regulatory filing confirming the validity of a report rather than the report itself, and it does not fit into specific categories like 10-K or IR, it is classified as a general regulatory filing.
2025-08-14 Japanese
半期報告書-第13期(2025/01/01-2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by '株式会社ファンペップ' (FunPep Company Limited) for the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, management analysis (MDA), and information on share capital and stock options. In the context of Japanese financial reporting, a '半期報告書' is the standard interim financial report required under the Financial Instruments and Exchange Act, which corresponds to the 'Interim / Quarterly Report' (IR) category in the provided schema. H1 2025
2025-08-14 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being filed because resolutions were passed at the "第12期定時株主総会" (12th Annual General Meeting) held on March 27, 2025. Section 2 details the resolutions, specifically the election of directors and a provisional auditor, along with the voting results (votes for, against, abstentions, and approval percentages). This content directly relates to the official results of a shareholder meeting. The most specific category for official results from shareholder votes is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a report about the AGM, the core content is the voting outcome, making DVA more precise than AGM-R (which is usually the presentation materials) or RNS (the general fallback).
2025-04-01 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.